JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 2, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/10/6893    most recent
C000569200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panka, D. J.
Right arrow Articles by Mier, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panka, D. J.
Right arrow Articles by Mier, J. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 5, 2001
J. Biol. Chem, 10.1074/jbc.C000569200
Submitted on August 21, 2000
Revised on January 5, 2001
Accepted on January 5, 2001

Phosphatidylinositol-3 Kinase/Akt activity regulates c-FLIP expression in tumor cells

David J. Panka, Toshiaki Mano, Toshimitsu Suhara, Kenneth Walsh, and James W. Mier

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115

Corresponding Author: jmier{at}caregroup.harvard.edu

The caspase-8 homologue Flice Inhibitory Protein (FLIP) functions as a caspase-8 dominant negative, blocking apoptosis induced by the oligomerization of the adapter protein FADD/MORT-1. FLIP expression correlates with resistance to apoptosis induced by various members of the TNF family such as TRAIL. Furthermore, forced expression of FLIP renders cells resistant to fas-mediated apoptosis. Although FLIP expression is regulated primarily by MEK1 activity in activated T cells, the oncogenic signaling pathways that regulate FLIP expression in tumor cells are largely unknown. In this report, we examined the roles of the MAP kinase and PI3-kinase signaling pathways in the regulation of FLIP expression in tumor cells. We observed that the MEK1 inhibitor PD98059 reduced FLIP levels in only two of eleven tumor cell lines tested. In contrast, disruption of the PI3-kinase pathway with the specific inhibitor LY294002 reduced Akt (pkB) phosphorylation and the levels of FLIP protein and mRNA in all cell lines evaluated. The introduction of a dominant negative Akt adenoviral construct also consistently reduced FLIP expression as well as the phosphorylation of the Akt target glycogen synthase kinase-3. In addition, infection of the same cell lines with a constitutively active Akt adenovirus increased FLIP expression and the phosphorylation of GSK-3. These data add FLIP to the growing list of apoptosis inhibitors whose expression or function are regulated by the PI3-kinase-Akt pathway.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
X. Wang, W. Chen, W. Zeng, L. Bai, Y. Tesfaigzi, S. A. Belinsky, and Y. Lin
Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells
Mol. Cancer Ther., May 1, 2008; 7(5): 1156 - 1163.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Hewamana, S. Alghazal, T. T. Lin, M. Clement, C. Jenkins, M. L. Guzman, C. T. Jordan, S. Neelakantan, P. A. Crooks, A. K. Burnett, et al.
The NF-{kappa}B subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Blood, May 1, 2008; 111(9): 4681 - 4689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. E. Perez, N. Parquet, K. Shain, R. Nimmanapalli, M. Alsina, C. Anasetti, and W. Dalton
Bone Marrow Stroma Confers Resistance to Apo2 Ligand/TRAIL in Multiple Myeloma in Part by Regulating c-FLIP
J. Immunol., February 1, 2008; 180(3): 1545 - 1555.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Chan, E. R. Bivins-Smith, M. S. Smith, and A. D. Yurochko
Transcriptome Analysis of NF-{kappa}B- and Phosphatidylinositol 3-Kinase-Regulated Genes in Human Cytomegalovirus-Infected Monocytes
J. Virol., January 15, 2008; 82(2): 1040 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Koschny, J. Sykora, H. Walczak, T. M. Ganten, T. L. Haas, M. R. Sprick, H. Holland, P. Ahnert, W. Krupp, J. Meixensberger, et al.
Bortezomib-Mediated Up-Regulation of TRAIL-R1 and TRAIL-R2 Is Not Necessary for but Contributes to Sensitization of Primary Human Glioma Cells to TRAIL
Clin. Cancer Res., November 1, 2007; 13(21): 6541 - 6542.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. A. Elrod, Y.-D. Lin, P. Yue, X. Wang, S. Lonial, F. R. Khuri, and S.-Y. Sun
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway
Mol. Cancer Ther., July 1, 2007; 6(7): 2029 - 2038.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Chen, J. Xu, N. Jhala, P. Pawar, Z. B. Zhu, L. Ma, C.-H. Byon, and J. M. McDonald
Fas-Mediated Apoptosis in Cholangiocarcinoma Cells Is Enhanced by 3,3'-Diindolylmethane through Inhibition of AKT Signaling and FLICE-Like Inhibitory Protein
Am. J. Pathol., November 1, 2006; 169(5): 1833 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Hu, C. Jiang, T. Schuster, G.-X. Li, P. T. Daniel, and J. Lu
Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Mol. Cancer Ther., July 1, 2006; 5(7): 1873 - 1882.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Lu, L. Wang, C. Stehlik, D. Medan, C. Huang, S. Hu, F. Chen, X. Shi, and Y. Rojanasakul
Phosphatidylinositol 3-Kinase/Akt Positively Regulates Fas (CD95)-Mediated Apoptosis in Epidermal Cl41 Cells.
J. Immunol., June 1, 2006; 176(11): 6785 - 6793.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Krueger, S. C. Fas, M. Giaisi, M. Bleumink, A. Merling, C. Stumpf, S. Baumann, D. Holtkotte, V. Bosch, P. H. Krammer, et al.
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)
Blood, May 15, 2006; 107(10): 3933 - 3939.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Saito, K. Meyer, R. Warner, A. Basu, R. B. Ray, and R. Ray
Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory Protein
J. Virol., May 1, 2006; 80(9): 4372 - 4379.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Bertram, J. W. Peacock, C. Tan, A. L-F. Mui, S. W. Chung, M. E. Gleave, S. Dedhar, M. E. Cox, and C. J. Ong
Inhibition of the Phosphatidylinositol 3'-Kinase Pathway Promotes Autocrine Fas-Induced Death of Phosphatase and Tensin Homologue-Deficient Prostate Cancer Cells.
Cancer Res., May 1, 2006; 66(9): 4781 - 4788.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. C. Li, M. J. Park, S.-K. Ye, C.-W. Kim, and Y.-N. Kim
Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents
Am. J. Pathol., April 1, 2006; 168(4): 1107 - 1118.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Sampath, J. Cortes, Z. Estrov, M. Du, Z. Shi, M. Andreeff, V. Gandhi, and W. Plunkett
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
Blood, March 15, 2006; 107(6): 2517 - 2524.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. P. Oyarzo, L. J. Medeiros, C. Atwell, M. Feretzaki, V. Leventaki, E. Drakos, H. M. Amin, and G. Z. Rassidakis
c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma
Blood, March 15, 2006; 107(6): 2544 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. G. Jones, S. D. Saibil, J. M. Pun, A. R. Elford, M. Bonnard, M. Pellegrini, S. Arya, M. E. Parsons, C. M. Krawczyk, S. Gerondakis, et al.
NF-{kappa}B Couples Protein Kinase B/Akt Signaling to Distinct Survival Pathways and the Regulation of Lymphocyte Homeostasis In Vivo
J. Immunol., September 15, 2005; 175(6): 3790 - 3799.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Voelkel-Johnson, Y. A. Hannun, and A. El-Zawahry
Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein
Mol. Cancer Ther., September 1, 2005; 4(9): 1320 - 1327.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Hu, C. Jiang, G. Li, and J. Lu
PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells
Carcinogenesis, August 1, 2005; 26(8): 1374 - 1381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Hashimoto, J. Nakajima-Shimada, and T. Aoki
Trypanosoma cruzi Posttranscriptionally Up-Regulates and Exploits Cellular FLIP for Inhibition of Death-inducing Signal
Mol. Biol. Cell, August 1, 2005; 16(8): 3521 - 3528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Poukkula, A. Kaunisto, V. Hietakangas, K. Denessiouk, T. Katajamaki, M. S. Johnson, L. Sistonen, and J. E. Eriksson
Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail
J. Biol. Chem., July 22, 2005; 280(29): 27345 - 27355.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Beier, J. Wischhusen, M. Gleichmann, E. Gerhardt, A. Pekanovic, A. Krueger, V. Taylor, U. Suter, P. H. Krammer, M. Endres, et al.
FasL (CD95L/APO-1L) Resistance of Neurons Mediated by Phosphatidylinositol 3-Kinase-Akt/Protein Kinase B-Dependent Expression of Lifeguard/Neuronal Membrane Protein 35
J. Neurosci., July 20, 2005; 25(29): 6765 - 6774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Bremer, D. F. Samplonius, L. van Genne, M. H. Dijkstra, B. J. Kroesen, L. F. M. H. de Leij, and W. Helfrich
Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR
J. Biol. Chem., March 18, 2005; 280(11): 10025 - 10033.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. X. Wu, J. La Rose, L. Chen, C. Neale, T. Mak, K. Okkenhaug, R. Wange, and R. Rottapel
CD28 Regulates the Translation of Bcl-xL via the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Pathway
J. Immunol., January 1, 2005; 174(1): 180 - 194.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-E. Kim and S. R. Tannenbaum
Insulin Regulates Cleavage of Procaspase-9 via Binding of X Chromosome-Linked Inhibitor of Apoptosis Protein in HT-29 Cells
Cancer Res., December 15, 2004; 64(24): 9070 - 9075.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhang, T.-G. Jin, H. Yang, W. C. DeWolf, R. Khosravi-Far, and A. F. Olumi
Persistent c-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer
Cancer Res., October 1, 2004; 64(19): 7086 - 7091.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Shah and P. W. Sylvester
Tocotrienol-Induced Caspase-8 Activation Is Unrelated to Death Receptor Apoptotic Signaling in Neoplastic Mammary Epithelial Cells
Experimental Biology and Medicine, September 1, 2004; 229(8): 745 - 755.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Nesterov, M. Nikrad, T. Johnson, and A. S. Kraft
Oncogenic Ras Sensitizes Normal Human Cells to Tumor Necrosis Factor-{alpha}-Related Apoptosis-Inducing Ligand-Induced Apoptosis
Cancer Res., June 1, 2004; 64(11): 3922 - 3927.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Suhara, K. Fukuo, O. Yasuda, M. Tsubakimoto, Y. Takemura, H. Kawamoto, T. Yokoi, M. Mogi, T. Kaimoto, and T. Ogihara
Homocysteine Enhances Endothelial Apoptosis via Upregulation of Fas-Mediated Pathways
Hypertension, June 1, 2004; 43(6): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Takemura, K. Fukuo, O. Yasuda, T. Inoue, N. Inomata, T. Yokoi, H. Kawamoto, T. Suhara, and T. Ogihara
Fas Signaling Induces Akt Activation and Upregulation of Endothelial Nitric Oxide Synthase Expression
Hypertension, April 1, 2004; 43(4): 880 - 884.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wang, Y. Zhou, H. P. Kim, R. Song, R. Zarnegar, S. W. Ryter, and A. M. K. Choi
Hepatocyte Growth Factor Protects against Hypoxia/Reoxygenation-induced Apoptosis in Endothelial Cells
J. Biol. Chem., February 13, 2004; 279(7): 5237 - 5243.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C.-L. Hu, R. G. Cowan, R. M. Harman, and S. M. Quirk
Cell Cycle Progression and Activation of Akt Kinase Are Required for Insulin-Like Growth Factor I-Mediated Suppression of Apoptosis in Granulosa Cells
Mol. Endocrinol., February 1, 2004; 18(2): 326 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Davies, J. Mason, M. J. O. Wakelam, L. S. Young, and A. G. Eliopoulos
Inhibition of Phosphatidylinositol 3-Kinase- and ERK MAPK-regulated Protein Synthesis Reveals the Pro-apoptotic Properties of CD40 Ligation in Carcinoma Cells
J. Biol. Chem., January 9, 2004; 279(2): 1010 - 1019.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Skurk, H. Maatz, H.-S. Kim, J. Yang, M. R. Abid, W. C. Aird, and K. Walsh
The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP
J. Biol. Chem., January 9, 2004; 279(2): 1513 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Q. Wang, T. Quan, T. He, T. F. Franke, J. J. Voorhees, and G. J. Fisher
Epidermal Growth Factor Receptor-dependent, NF-{kappa}B-independent Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Inhibits Ultraviolet Irradiation-induced Caspases-3, -8, and -9 in Human Keratinocytes
J. Biol. Chem., November 14, 2003; 278(46): 45737 - 45745.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Panka and J. W. Mier
Canstatin Inhibits Akt Activation and Induces Fas-dependent Apoptosis in Endothelial Cells
J. Biol. Chem., September 26, 2003; 278(39): 37632 - 37636.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Kuenzi, P. Schneider, and D. A. E. Dobbelaere
Theileria parva-Transformed T Cells Show Enhanced Resistance to Fas/Fas Ligand-Induced Apoptosis
J. Immunol., August 1, 2003; 171(3): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Asakuma, M. Sumitomo, T. Asano, T. Asano, and M. Hayakawa
Selective Akt Inactivation and Tumor Necrosis Factor-related Apoptosis-inducing Ligand Sensitization of Renal Cancer Cells by Low Concentrations of Paclitaxel
Cancer Res., March 15, 2003; 63(6): 1365 - 1370.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. W. Lee, Y. Park, J. K. Yoo, S. Y. Choi, and Y. C. Sung
Inhibition of TCR-Induced CD8 T Cell Death by IL-12: Regulation of Fas Ligand and Cellular FLIP Expression and Caspase Activation by IL-12
J. Immunol., March 1, 2003; 170(5): 2456 - 2460.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. F. Yang, C. Xiao, W. H. Roa, P. H. Krammer, and C. Hao
Calcium/Calmodulin-dependent Protein Kinase II Regulation of c-FLIP Expression and Phosphorylation in Modulation of Fas-mediated Signaling in Malignant Glioma Cells
J. Biol. Chem., February 21, 2003; 278(9): 7043 - 7050.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Nitobe, S. Yamaguchi, M. Okuyama, N. Nozaki, M. Sata, T. Miyamoto, Y. Takeishi, I. Kubota, and H. Tomoike
Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes
Cardiovasc Res, January 1, 2003; 57(1): 119 - 128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. H. Li, M. S. Kluger, L. A. Madge, L. Zheng, A. L. M. Bothwell, and J. S. Pober
Interferon-{gamma} Augments CD95(APO-1/Fas) and Pro-Caspase-8 Expression and Sensitizes Human Vascular Endothelial Cells to CD95-Mediated Apoptosis
Am. J. Pathol., October 1, 2002; 161(4): 1485 - 1495.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
R. G. Jones, A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W.-C. Yeh, R. Hakem, R. Rottapel, J. R. Woodgett, and P. S. Ohashi
CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly
J. Exp. Med., August 5, 2002; 196(3): 335 - 348.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Poulaki, C. S. Mitsiades, V. Kotoula, S. Tseleni-Balafouta, A. Ashkenazi, D. A. Koutras, and N. Mitsiades
Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma Cells
Am. J. Pathol., August 1, 2002; 161(2): 643 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Xiao, B. F. Yang, N. Asadi, F. Beguinot, and C. Hao
Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells
J. Biol. Chem., July 5, 2002; 277(28): 25020 - 25025.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Q. Wang, N. Li, X. Wang, M. M. Kim, and B. M. Evers
Augmentation of Sodium Butyrate-induced Apoptosis by Phosphatidylinositol 3'-Kinase Inhibition in the KM20 Human Colon Cancer Cell Line
Clin. Cancer Res., June 1, 2002; 8(6): 1940 - 1947.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. A. Lawlor and D. R. Alessi
PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?
J. Cell Sci., March 10, 2002; 114(16): 2903 - 2910.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. H. Shain, T. H. Landowski, and W. S. Dalton
Adhesion-Mediated Intracellular Redistribution of c-Fas-Associated Death Domain-Like IL-1-Converting Enzyme-Like Inhibitory Protein-Long Confers Resistance to CD95-Induced Apoptosis in Hematopoietic Cancer Cell Lines
J. Immunol., March 1, 2002; 168(5): 2544 - 2553.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Kelly, A. Won, Y. Refaeli, and L. V. Parijs
IL-2 and Related Cytokines Can Promote T Cell Survival by Activating AKT
J. Immunol., January 15, 2002; 168(2): 597 - 603.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Krueger, S. Baumann, P. H. Krammer, and S. Kirchhoff
FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis
Mol. Cell. Biol., December 15, 2001; 21(24): 8247 - 8254.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. Hatano and D. A. Brenner
Akt protects mouse hepatocytes from TNF-alpha - and Fas-mediated apoptosis through NK-kappa B activation
Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1357 - G1368.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Monick, R. K. Mallampalli, A. B. Carter, D. M. Flaherty, D. McCoy, P. K. Robeff, M. W. Peterson, and G. W. Hunninghake
Ceramide Regulates Lipopolysaccharide-Induced Phosphatidylinositol 3-Kinase and Akt Activity in Human Alveolar Macrophages
J. Immunol., November 15, 2001; 167(10): 5977 - 5985.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Qiao, E. Studer, K. Leach, R. McKinstry, S. Gupta, R. Decker, R. Kukreja, K. Valerie, P. Nagarkatti, W. E. Deiry, et al.
Deoxycholic Acid (DCA) Causes Ligand-independent Activation of Epidermal Growth Factor Receptor (EGFR) and FAS Receptor in Primary Hepatocytes: Inhibition of EGFR/Mitogen-activated Protein Kinase-Signaling Module Enhances DCA-induced Apoptosis
Mol. Biol. Cell, September 1, 2001; 12(9): 2629 - 2645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. F. Burns and W. S. El-Deiry
Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic Approach
J. Biol. Chem., October 5, 2001; 276(41): 37879 - 37886.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Suhara, T. Mano, B. E. Oliveira, and K. Walsh
Phosphatidylinositol 3-Kinase/Akt Signaling Controls Endothelial Cell Sensitivity to Fas-Mediated Apoptosis via Regulation of FLICE-Inhibitory Protein (FLIP)
Circ. Res., July 6, 2001; 89(1): 13 - 19.
[Abstract] [Full Text] [PDF]